Mutations of SMARCA2 are rarely observed but gene silencing related to epigenetic regulation in tumor has been reported [48,49], which is in line with strong hypermethylation observed in our Fusobacterium-enriched HNSCC tumor tissues when compared to Fusobacterium-low tumor tissues. This evidence concerns the gene SMARCA2 and head and neck squamous cell carcinoma.